Risankizumab improves clinical remission rates of moderate to high active ulcerative colitis, finds research Jacinthlyn Sylvia26 July 2024 9:00 PM ISTA recent research published in the Journal of American Medical Association found that risankizumab improved clinical remission rates in an induction...
Coconut water more effective than placebo for inducing clinical remission in patients with mild to moderate ulcerative colitis: Study Dr. Shravani Dali24 Jun 2024 9:00 AM ISTCoconut water is more effective than a placebo for inducing clinical remission in patients with mild to moderate ulcerative colitis suggests a study...
JnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease Ruchika Sharma22 Jun 2024 2:21 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease Ruchika Sharma5 May 2024 1:30 PM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced it has submitted applications to the European Medicines...
New Study Reveals Comparable Postoperative Risks of Tofacitinib and Biologics in Ulcerative Colitis Patients Dr.Niharika Harsha B15 April 2024 6:45 AM ISTIn a significant breakthrough, a recent multicenter retrospective study has shed light on the postoperative outcomes of ulcerative colitis (UC)...
Eli Lilly Gets CDSCO Panel Nod To Market Mirikizumab for ulcerative colitis in adults Dr. Divya Colin7 April 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got marketing authorization from the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal For Study of SAR443122 in Ulcerative Colitis Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Johnson & Johnson seeks USFDA nod for Tremfya for ulcerative colitis treatment in adults Ruchika Sharma12 March 2024 12:39 PM ISTSpring House: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
Sun Pharma unit recalls over 54000 bottles of Mesalamine ER capsules in US Ruchika Sharma9 March 2024 11:24 AM ISTThe affected lot of capsules have been manufactured by Sun Pharmaceutical Industries at its Mohali-based manufacturing plant and distributed in the US...
Pfizer gets EU nod for ulcerative colitis drug Velsipity Ruchika Sharma20 Feb 2024 11:30 AM ISTThe approval, applicable in all 27 countries of the European Union, is based on studies from two late-stage trials that showed the drug was effective...
Saffron Promising in Reducing the Symptoms of Ulcerative Colitis: Study Jacinthlyn Sylvia12 Feb 2024 9:15 PM ISTA study conducted at Yazd University explored the therapeutic benefits of saffron as an additional intervention to improve clinical manifestations in...
Hypoalbuminemia linked to severe ED in ulcerative colitis patients: Study Medha Baranwal8 Feb 2024 6:00 PM ISTJapan: A cross-sectional study published in the International Journal of Urology has shed light on serum albumin levels as a useful complementary...
